Does SVB Leerink have the potential to turn into an EB? The senior hiring they have been doing as of late is super impressive. Just curious what everyone's thoughts are on the bank's outlook.
| +158 | UBS Tech layoff | 52 | 22h |
| +147 | Analyst: Why is UBS IB doing worse than peers?, UBS CFO: No Comment | 23 | 2h |
| +145 | UBS’s M&A BANKERS ARE DOING TERRIBLY. $200M EXTRA IS BEING CUT | 31 | 1h |
| +60 | Are target prospects getting dumber? | 27 | 13m |
| +58 | How do YOU manage networking requests? | 17 | 7h |
| +48 | Leaked Interview Questions to Recruiting Services | 31 | 13m |
| +36 | Quitting After First 4 months | 12 | 1d |
| +34 | MBB Pay Raises | 26 | 1d |
| +33 | Cornell Club T10 Rankings (UPDATED 10/2026) | 19 | 1d |
| +19 | Career Crossroads | 2 | 1d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Considering it's a meaningless term used strictly on WSO, sure. This is the wrong question to be asking. It's a good platform with quality professionals working on interesting deals. What it's called on WSO hardly matters.
Seems to be a lot of Cain Bros and Torreya guys giving you MS. Leerink's growth is definitely impressive, but I'm not quite sure what really constitutes an EB. Will Leerink be successfully competing for $10+ billion M&A deals? I have no clue. But the growth of their firm is certainly impressive, and I'd imagine it's a top place to be for future PE/GE/VC recruiting, particularly with respect to life sciences. Will it be the Qatalyst of HC? That's a tough hurdle to hop over, but Leerink is definitely a great place to be if you want to focus on healthcare. Certainly a top-end shop.